{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T18:29:05Z","timestamp":1781720945534,"version":"3.54.5"},"publisher-location":"New York, NY","reference-count":4,"publisher":"Springer New York","isbn-type":[{"value":"9781493932917","type":"print"},{"value":"9781493932924","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3292-4_17","type":"book-chapter","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T17:43:37Z","timestamp":1458323017000},"page":"325-338","source":"Crossref","is-referenced-by-count":1,"title":["Identification and Analysis of Antiviral Compounds Against Poliovirus"],"prefix":"10.1007","author":[{"given":"Pieter","family":"Leyssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aloys","family":"Tijsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"De Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"17_CR3","first-page":"2649","volume":"20","author":"P Minor","year":"2005","unstructured":"Minor P (2005) Vaccine-derived poliovirus (VDPV): impact on poliomyelitis eradication. Vaccine 20:2649\u20132652","journal-title":"Vaccine"},{"key":"17_CR4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","volume":"59","author":"O Ken","year":"2005","unstructured":"Ken O, Sutter RW, de Gourville EM, Dowdl WR, Pallansch MA (2005) Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 59:587\u2013635","journal-title":"Annu Rev Microbiol"},{"key":"17_CR5","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1126\/science.311.5767.1539a","volume":"311","author":"J Couzin","year":"2006","unstructured":"Couzin J (2006) Report concludes polio drugs are needed, after disease is eradicated. Science 311:1539","journal-title":"Science"},{"key":"17_CR6","unstructured":"http:\/\/www.promega.es\/~\/media\/files\/resources\/promega%20notes\/75\/a%20highthroughput%20system%20for%20screening%20potential%20antiviral%20compounds.pdf?la=es-ES"}],"container-title":["Methods in Molecular Biology","Poliovirus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3292-4_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T19:12:37Z","timestamp":1675883557000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4939-3292-4_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493932917","9781493932924"],"references-count":4,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3292-4_17","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}